Featured Publications
The 14-year course of alcoholism in a community sample: Do men and women differ?
Edens EL, Glowinski AL, Grazier KL, Bucholz KK. The 14-year course of alcoholism in a community sample: Do men and women differ? Drug And Alcohol Dependence 2007, 93: 1-11. PMID: 17935914, PMCID: PMC2324065, DOI: 10.1016/j.drugalcdep.2007.08.013.Peer-Reviewed Original ResearchConceptsAlcohol abusePast-year DSM-IV alcohol dependenceDSM-III alcohol abuseDSM-IV AUD criteriaPast-year alcohol use disorderCommunity sampleHealth service useCase-control studyEpidemiologic Catchment Area studyDSM-III criteriaDSM-IV alcohol dependencePatterns of drinkingCatchment Area StudyAlcohol use disorderDSM-IV alcohol abuseCourse of alcoholismRisk drinkingService useUse disordersClinical relevanceHeavy drinkersLifetime ratesAlcohol dependenceUnaffected controlsAlcohol use behaviors
2013
Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence
Ralevski E, Jane J, O’Brien E, Edens E, Arnaout B, Kerfoot K, Keegan K, Weiner J, Russo M, Petrakis I. Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence. Journal Of Dual Diagnosis 2013, 9: 301-310. DOI: 10.1080/15504263.2013.835163.Peer-Reviewed Original ResearchDepressive symptomsAlcohol dependenceDual diagnosisRates of smokingMain outcome variablesSymptoms of depressionTreatment of peopleTreatment trialsComorbid depressionMecamylamineSide effectsNonsmokersSmokingSymptomsOutcome variablesBest treatmentDrinking outcomesDepressionPlaceboSmokersFurther studiesSignificant differencesDiagnosisParticipantsTreatment
2011
Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence
Ralevski E, O’Brien E, Jane JS, Dwan R, Dean E, Edens E, Arnaout B, Keegan K, Drew S, Petrakis I. Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence. Journal Of Dual Diagnosis 2011, 7: 64-73. PMID: 26954912, DOI: 10.1080/15504263.2011.569440.Peer-Reviewed Original ResearchEfficacy of acamprosateAlcohol dependenceSchizophrenia spectrum disordersMedication treatmentComorbid schizophreniaSignificant group x time interactionGroup x time interactionComorbid alcohol dependenceAlcohol use disorderSymptoms of schizophreniaX time interactionAcamprosate groupComorbid conditionsTreatment trialsAbstinent patientsClinical trialsSpectrum disorderAcamprosateGeneral populationUse disordersPatientsSchizoaffective disorderPositive symptomsSchizophrenic symptomsConsecutive days